CJC-1295 (With DAC)

(28 customer reviews)

Price range: $49.00 through $99.00 USD

CJC-1295 with DAC is a modified analogue of growth-hormone-releasing hormone (GHRH) that carries a drug affinity complex modification designed to extend its activity. Supplied for in-vitro laboratory research. Each lot is supplied with its own Certificate of Analysis.

Form and sizeLyophilized vial
For laboratory research use only. Not for human or animal consumption. Not a drug. Not evaluated by the FDA.
  • Certificate of Analysis for every lot
  • HPLC and mass spectrometry testing for every lot
  • Lot number on every vial and report
  • Protective, discreet packaging
SKU: N/A Category:

Description

About this material

CJC-1295 with DAC is a modified analogue of growth-hormone-releasing hormone (GHRH) that carries a drug affinity complex modification designed to extend its activity. MICROGRAMBIO supplies CJC-1295 as a lyophilized powder in a sealed vial for in-vitro laboratory research. Each lot comes with its own Certificate of Analysis, so you can check the identity and the results for the exact vial you receive.

Research context

In the laboratory literature, CJC-1295 is discussed in work on GHRH receptor signalling and the effect of half-life-extending modifications on peptides. Researchers use it as a tool to examine these systems in cell-based and other in-vitro models.

Published work comes from many laboratories that use different models, methods and conditions, and a result in one system does not carry over to another. Nothing on this page describes an effect in people or animals. Review the primary literature when you design your own study.

Research focus

  • GHRH receptor signalling
  • The effect of half-life-extending modifications on peptides
  • Growth-hormone axis pathways in cell-based assays

Please note

Confirm the exact identity on the Certificate of Analysis, because CJC-1295 is sold in several forms.

What you receive

  • A sealed vial of lyophilized powder, in the size you choose above
  • A Certificate of Analysis for the lot, with the testing methods and results
  • A lot number printed on the vial and on the report
  • Protective, discreet packaging

Handling and documentation

Follow the storage instructions on the label and on the report for your lot, together with your laboratory's own procedures. Keep the vial sealed until you need it, and record the lot number, the date you received it and your storage conditions in your laboratory notes. If you need help reading the report, use the guides below or contact us with your order and lot numbers.

Related reading

How to read a peptide Certificate of Analysis · HPLC explained · Storage and handling basics

Specifications

Size

5 mg, 10 mg, 15 mg, 20 mg

Material type

Peptide

Form

Lyophilized powder in a sealed vial

Storage

As stated on the label and the report for your lot

For laboratory research use only. Not for human or animal consumption.

Key features

  • Certificate of Analysis supplied for every lot
  • Testing methods and results listed on the lot report
  • Lot number printed on the vial and on the report
  • Supplied as a sealed lyophilized vial
  • Four vial sizes: 5, 10, 15 and 20 mg
  • Protective, discreet packaging
  • For laboratory research use only

How this lot of CJC-1295 (With DAC) is verified

Identity

Mass spectrometry measures the molecular weight of the material so you can confirm the compound in the vial matches the label.

Purity

HPLC shows how much of the sample is the target peptide. The result is written into the report for your lot.

Documentation

The Certificate of Analysis is tied to your lot number. Compare it with the label before you use the material. See our testing process.

Storage and handling

Follow the storage instructions on the label and on the report for your lot, together with your laboratory's own procedures. As general laboratory practice, lyophilized material is kept sealed, dry, protected from light and cold. Record dates and conditions in your laboratory notes.

Questions about CJC-1295 (With DAC)

Is CJC-1295 (With DAC) for human or animal use?

No. CJC-1295 (With DAC) is supplied for laboratory research use only. It is not a drug, is not for human or animal consumption, and is not intended to diagnose, treat, cure or prevent any condition.

Where do I find the lot number and report?

The lot number is printed on the vial label. The Certificate of Analysis for the current lot is linked on this page, and your order confirmation and account show the lot you received.

How is CJC-1295 (With DAC) tested?

Each lot is analysed using HPLC for purity and mass spectrometry for identity, and the results are written into the report for that lot.

Who can buy CJC-1295 (With DAC)?

Qualified researchers and laboratories aged 21 or over. You confirm this when you enter the site and again at checkout.

Where do you ship?

Delivery options and countries are shown at checkout.

More answers on our FAQ page.

Reviews

28 reviews for CJC-1295 (With DAC)

  1. Mary Torres –

    Top-Tier Research Stack: CJC-1295 (With DAC) and Hexarelin

    Combining CJC-1295 (With DAC) and Hexarelin created a remarkable dual-action response. We observed clean activation where CJC-1295 (With DAC) excelled at sustaining elevated baseline growth hormone and IGF-1 levels over an extended multi-day half-life, and Hexarelin stepped in to deliver inducing rapid growth hormone pulses, supporting cardiac muscle health, and accelerating physical recovery. The purity of both compounds was top-notch with zero unexpected side effects.

  2. Brian Robinson –

    Outstanding Results with the CJC-1295 (With DAC) & Semaglutide Combo

    Stacking CJC-1295 (With DAC) and Semaglutide provides a complete, well-rounded protocol. CJC-1295 (With DAC) acts as a baseline by sustaining elevated baseline growth hormone and IGF-1 levels over an extended multi-day half-life, whereas Semaglutide adds synergistic value through effectively reducing appetite, suppressing cravings, and improving glycemic metrics. Both vials dissolved effortlessly without residue.

  3. Matthew Anderson –

    Impressive Synergy: CJC-1295 (With DAC) and Survodutide Dual Protocol

    This combination of CJC-1295 (With DAC) and Survodutide exceeded expectations in our trial run. The inclusion of CJC-1295 (With DAC) was vital for sustaining elevated baseline growth hormone and IGF-1 levels over an extended multi-day half-life, while Survodutide amplified overall outcomes by boosting energy expenditure, promoting liver fat clearance, and controlling caloric intake. Packaging arrived cold and intact, and batch testing confirmed supreme quality.

  4. Stephanie Gomez –

    Highly Effective Pair: CJC-1295 (With DAC) paired with GHRP-2

    Integrating CJC-1295 (With DAC) alongside GHRP-2 in our testing protocol yielded exceptional synergy. CJC-1295 (With DAC) provided reliable support for sustaining elevated baseline growth hormone and IGF-1 levels over an extended multi-day half-life, while GHRP-2 complemented the protocol perfectly by delivering robust pulsatile growth hormone secretion with a mild appetite stimulation profile. Both reconstitute cleanly and show outstanding stability. Highly recommended for advanced research.

  5. Scott Allen –

    Top-Tier Research Stack: CJC-1295 (With DAC) and CJC-1295 + Ipamorelin Blend

    If you are looking to stack complementary peptides, pairing CJC-1295 (With DAC) with CJC-1295 + Ipamorelin Blend is an absolute winner. CJC-1295 (With DAC) shines for sustaining elevated baseline growth hormone and IGF-1 levels over an extended multi-day half-life, and when stacked with CJC-1295 + Ipamorelin Blend, you gain the additional benefit of maximizing pulsatile growth hormone secretion via dual receptor pathway co-activation. Reconstitution was smooth and instantaneous.

  6. Jerry Torres –

    Lab Protocol Test: Combining CJC-1295 (With DAC) with Tirzepatide

    Our research team ran a 4-week protocol testing CJC-1295 (With DAC) together with Tirzepatide. The results were noticeable from week one: CJC-1295 (With DAC) targeted sustaining elevated baseline growth hormone and IGF-1 levels over an extended multi-day half-life, while Tirzepatide enhanced overall effectiveness by delivering powerful weight loss, insulin sensitivity improvements, and metabolic regulation. Very clean product line and fast shipping.

  7. Jessica King –

    Game-Changer Stack: CJC-1295 (With DAC) + Sermorelin Review

    This combination of CJC-1295 (With DAC) and Sermorelin exceeded expectations in our trial run. The inclusion of CJC-1295 (With DAC) was vital for sustaining elevated baseline growth hormone and IGF-1 levels over an extended multi-day half-life, while Sermorelin amplified overall outcomes by stimulating natural pituitary GH output, enhancing recovery quality, supporting deep sleep, and overall vitality. Packaging arrived cold and intact, and batch testing confirmed supreme quality.

  8. Kimberly Brown –

    A Must-Try Combination: CJC-1295 (With DAC) & Liraglutide

    Integrating CJC-1295 (With DAC) alongside Liraglutide in our testing protocol yielded exceptional synergy. CJC-1295 (With DAC) provided reliable support for sustaining elevated baseline growth hormone and IGF-1 levels over an extended multi-day half-life, while Liraglutide complemented the protocol perfectly by supporting daily blood glucose stabilization, appetite control, and sustained weight management. Both reconstitute cleanly and show outstanding stability. Highly recommended for advanced research.

  9. Angela Thomas –

    Game-Changer Stack: CJC-1295 (With DAC) + CagriSema (Cagrilintide + Semaglutide Combo) Review

    Exceptional dual protocol. Using CJC-1295 (With DAC) in conjunction with CagriSema (Cagrilintide + Semaglutide Combo) maximized total trial efficiency. CJC-1295 (With DAC) was key for sustaining elevated baseline growth hormone and IGF-1 levels over an extended multi-day half-life, and CagriSema (Cagrilintide + Semaglutide Combo) ensured targeting dual satiety and hunger pathways for potent, comprehensive body weight management. The batch purity report matched our independent verification completely.

  10. Pamela Taylor –

    Incredible Synergistic Effects from CJC-1295 (With DAC) and Cagrilintide

    If you are looking to stack complementary peptides, pairing CJC-1295 (With DAC) with Cagrilintide is an absolute winner. CJC-1295 (With DAC) shines for sustaining elevated baseline growth hormone and IGF-1 levels over an extended multi-day half-life, and when stacked with Cagrilintide, you gain the additional benefit of promoting early satiety, delaying gastric emptying, and reducing food cravings independently of GLP-1. Reconstitution was smooth and instantaneous.

  11. Andrew Hall –

    Impressive Synergy: CJC-1295 (With DAC) and Survodutide Dual Protocol

    Exceptional dual protocol. Using CJC-1295 (With DAC) in conjunction with Survodutide maximized total trial efficiency. CJC-1295 (With DAC) was key for sustaining elevated baseline growth hormone and IGF-1 levels over an extended multi-day half-life, and Survodutide ensured boosting energy expenditure, promoting liver fat clearance, and controlling caloric intake. The batch purity report matched our independent verification completely.

  12. Angela Reyes –

    A Must-Try Combination: CJC-1295 (With DAC) & Liraglutide

    Our research team ran a 4-week protocol testing CJC-1295 (With DAC) together with Liraglutide. The results were noticeable from week one: CJC-1295 (With DAC) targeted sustaining elevated baseline growth hormone and IGF-1 levels over an extended multi-day half-life, while Liraglutide enhanced overall effectiveness by supporting daily blood glucose stabilization, appetite control, and sustained weight management. Very clean product line and fast shipping.

  13. Angela Williams –

    Optimal Results Using CJC-1295 (With DAC) and Mazdutide Together

    If you are looking to stack complementary peptides, pairing CJC-1295 (With DAC) with Mazdutide is an absolute winner. CJC-1295 (With DAC) shines for sustaining elevated baseline growth hormone and IGF-1 levels over an extended multi-day half-life, and when stacked with Mazdutide, you gain the additional benefit of driving significant body weight reduction and optimizing glycemic control markers. Reconstitution was smooth and instantaneous.

  14. Stephen Perez –

    Incredible Synergistic Effects from CJC-1295 (With DAC) and Cagrilintide

    Combining CJC-1295 (With DAC) with Cagrilintide has proven to be one of the most effective protocols in our catalog. CJC-1295 (With DAC) effectively handles sustaining elevated baseline growth hormone and IGF-1 levels over an extended multi-day half-life, while Cagrilintide works in tandem to ensure promoting early satiety, delaying gastric emptying, and reducing food cravings independently of GLP-1. Consistent potency and exceptional quality.

  15. Barbara Parker –

    Seamless Integration of CJC-1295 (With DAC) with Ipamorelin

    Combining CJC-1295 (With DAC) with Ipamorelin has proven to be one of the most effective protocols in our catalog. CJC-1295 (With DAC) effectively handles sustaining elevated baseline growth hormone and IGF-1 levels over an extended multi-day half-life, while Ipamorelin works in tandem to ensure providing clean, selective growth hormone release without elevating cortisol, prolactin, or appetite. Consistent potency and exceptional quality.

  16. Steven Parker –

    Seamless Integration of CJC-1295 (With DAC) with Dulaglutide

    Stacking CJC-1295 (With DAC) and Dulaglutide provides a complete, well-rounded protocol. CJC-1295 (With DAC) acts as a baseline by sustaining elevated baseline growth hormone and IGF-1 levels over an extended multi-day half-life, whereas Dulaglutide adds synergistic value through providing long-acting glycemic control, metabolic stability, and appetite reduction. Both vials dissolved effortlessly without residue.

  17. Rachel Thomas –

    Highly Effective Pair: CJC-1295 (With DAC) paired with Tesamorelin

    This combination of CJC-1295 (With DAC) and Tesamorelin exceeded expectations in our trial run. The inclusion of CJC-1295 (With DAC) was vital for sustaining elevated baseline growth hormone and IGF-1 levels over an extended multi-day half-life, while Tesamorelin amplified overall outcomes by targeting visceral abdominal fat reduction, stimulating endogenous growth hormone release, and elevating IGF-1. Packaging arrived cold and intact, and batch testing confirmed supreme quality.

  18. Rebecca Phillips –

    Lab Protocol Test: Combining CJC-1295 (With DAC) with Tirzepatide

    Integrating CJC-1295 (With DAC) alongside Tirzepatide in our testing protocol yielded exceptional synergy. CJC-1295 (With DAC) provided reliable support for sustaining elevated baseline growth hormone and IGF-1 levels over an extended multi-day half-life, while Tirzepatide complemented the protocol perfectly by delivering powerful weight loss, insulin sensitivity improvements, and metabolic regulation. Both reconstitute cleanly and show outstanding stability. Highly recommended for advanced research.

  19. Katherine Rodriguez –

    Optimal Results Using CJC-1295 (With DAC) and Mazdutide Together

    Combining CJC-1295 (With DAC) with Mazdutide has proven to be one of the most effective protocols in our catalog. CJC-1295 (With DAC) effectively handles sustaining elevated baseline growth hormone and IGF-1 levels over an extended multi-day half-life, while Mazdutide works in tandem to ensure driving significant body weight reduction and optimizing glycemic control markers. Consistent potency and exceptional quality.

  20. Elizabeth White –

    Top-Tier Research Stack: CJC-1295 (With DAC) and Retatrutide + Cagrilintide Combo

    Stacking CJC-1295 (With DAC) and Retatrutide + Cagrilintide Combo provides a complete, well-rounded protocol. CJC-1295 (With DAC) acts as a baseline by sustaining elevated baseline growth hormone and IGF-1 levels over an extended multi-day half-life, whereas Retatrutide + Cagrilintide Combo adds synergistic value through delivering unmatched weight loss, appetite suppression, and metabolic energy balance. Both vials dissolved effortlessly without residue.

  21. Dennis Taylor –

    Seamless Integration of CJC-1295 (With DAC) with MOTS-c

    Combining CJC-1295 (With DAC) with MOTS-c has proven to be one of the most effective protocols in our catalog. CJC-1295 (With DAC) effectively handles sustaining elevated baseline growth hormone and IGF-1 levels over an extended multi-day half-life, while MOTS-c works in tandem to ensure promoting AMPK activation, metabolic balance, cellular energy production, and exercise capacity. Consistent potency and exceptional quality.

  22. Donald Flores –

    Seamless Integration of CJC-1295 (With DAC) with Dulaglutide

    Combining CJC-1295 (With DAC) and Dulaglutide created a remarkable dual-action response. We observed clean activation where CJC-1295 (With DAC) excelled at sustaining elevated baseline growth hormone and IGF-1 levels over an extended multi-day half-life, and Dulaglutide stepped in to deliver providing long-acting glycemic control, metabolic stability, and appetite reduction. The purity of both compounds was top-notch with zero unexpected side effects.

  23. Dennis Perez –

    Outstanding Results with the CJC-1295 (With DAC) & Semaglutide Combo

    Combining CJC-1295 (With DAC) and Semaglutide created a remarkable dual-action response. We observed clean activation where CJC-1295 (With DAC) excelled at sustaining elevated baseline growth hormone and IGF-1 levels over an extended multi-day half-life, and Semaglutide stepped in to deliver effectively reducing appetite, suppressing cravings, and improving glycemic metrics. The purity of both compounds was top-notch with zero unexpected side effects.

  24. Sharon King –

    Optimal Results Using CJC-1295 (With DAC) and HGH 191AA Together

    Combining CJC-1295 (With DAC) and HGH 191AA created a remarkable dual-action response. We observed clean activation where CJC-1295 (With DAC) excelled at sustaining elevated baseline growth hormone and IGF-1 levels over an extended multi-day half-life, and HGH 191AA stepped in to deliver enhancing cellular regeneration, collagen synthesis, lean muscle preservation, and joint resilience. The purity of both compounds was top-notch with zero unexpected side effects.

  25. Eric Perez –

    Lab Protocol Test: Combining CJC-1295 (With DAC) with GHRP-6

    Our research team ran a 4-week protocol testing CJC-1295 (With DAC) together with GHRP-6. The results were noticeable from week one: CJC-1295 (With DAC) targeted sustaining elevated baseline growth hormone and IGF-1 levels over an extended multi-day half-life, while GHRP-6 enhanced overall effectiveness by strongly stimulating growth hormone release while boosting appetite signaling and digestive motility. Very clean product line and fast shipping.

  26. Rebecca Garcia –

    Top-Tier Research Stack: CJC-1295 (With DAC) and Retatrutide + Cagrilintide Combo

    Combining CJC-1295 (With DAC) and Retatrutide + Cagrilintide Combo created a remarkable dual-action response. We observed clean activation where CJC-1295 (With DAC) excelled at sustaining elevated baseline growth hormone and IGF-1 levels over an extended multi-day half-life, and Retatrutide + Cagrilintide Combo stepped in to deliver delivering unmatched weight loss, appetite suppression, and metabolic energy balance. The purity of both compounds was top-notch with zero unexpected side effects.

  27. Donald Robinson –

    Top-Tier Research Stack: CJC-1295 (With DAC) and CJC-1295 (No DAC)

    Stacking CJC-1295 (With DAC) and CJC-1295 (No DAC) provides a complete, well-rounded protocol. CJC-1295 (With DAC) acts as a baseline by sustaining elevated baseline growth hormone and IGF-1 levels over an extended multi-day half-life, whereas CJC-1295 (No DAC) adds synergistic value through providing sharp, physiological growth hormone pulses when paired with a growth hormone secretagogue. Both vials dissolved effortlessly without residue.

  28. Gary Brown –

    Game-Changer Stack: CJC-1295 (With DAC) + CagriSema (Cagrilintide + Semaglutide Combo) Review

    This combination of CJC-1295 (With DAC) and CagriSema (Cagrilintide + Semaglutide Combo) exceeded expectations in our trial run. The inclusion of CJC-1295 (With DAC) was vital for sustaining elevated baseline growth hormone and IGF-1 levels over an extended multi-day half-life, while CagriSema (Cagrilintide + Semaglutide Combo) amplified overall outcomes by targeting dual satiety and hunger pathways for potent, comprehensive body weight management. Packaging arrived cold and intact, and batch testing confirmed supreme quality.

Add a review

Your email address will not be published. Required fields are marked *